Increased cervical cancer incidence in the target age of screening—Variation by mode of detection
What's New? Cervical cancer rates have risen in several high‐income countries despite advances in screening. Here, using data on cervical cancer diagnoses between 1996 and 2022 in Finland, the authors examined incidence trends according to detection mode—screening, between screenings, or outside screening programs—with attention to the role of human ...
Jenna Snellman +4 more
wiley +1 more source
Age-Related Trends in Corneal Refractive Parameters: A Fourier Analysis of Videokeratography in Healthy Eyes. [PDF]
Tan S, Liu Z, Li Y, Li X, Tong Y, Li X.
europepmc +1 more source
What's New? Colorectal cancer (CRC) recurrence is a significant threat to survival despite surgery with curative intent. The characteristics of CRC recurrence, however, remain poorly understood, challenging postoperative surveillance. This study investigated post‐recurrence mortality and associations between time‐to‐recurrence and mortality among stage
Jesper Nors +3 more
wiley +1 more source
Prognostic Superiority of the White Cell-to-Lymphocyte Ratio (WLR) in Predicting Overall Survival in Patients With Gliomas. [PDF]
Zhang X, Cai G, Zhang H, Zhang Y.
europepmc +1 more source
What's New? Although screening reduces prostate cancer mortality, concerns about overdiagnosis and unnecessary biopsies have given rise to more tailored strategies. The European Association of Urology (EAU) proposed a risk‐adapted screening strategy combining prostate‐specific antigen (PSA)‐based intervals, a risk calculator, and magnetic resonance ...
Zhenwei Yang +5 more
wiley +1 more source
Predictive Value of Serum N-Terminal pro-B-Type Natriuretic Peptide and Troponin T for Incident Heart Failure: A Meta-Analysis of 9 International Cohorts. [PDF]
Bansal N +17 more
europepmc +1 more source
Long‐term benefit from adjuvant tamoxifen therapy for ER+ HER2− breast cancer by PR positivity
What's New? Tamoxifen is a cornerstone of endocrine therapy for estrogen receptor (ER)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer. Its long‐term benefits, however, may vary by progesterone receptor (PR) status. Here, using data from the Stockholm tamoxifen trials, the authors evaluated whether PR expression predicts
Anna E. Nordenskjöld +8 more
wiley +1 more source
Abstract Background The triglyceride‐glucose body mass index (TyG‐BMI) is a novel indicator combining an insulin resistance proxy (TyG index) with adiposity. It remains unclear how TyG‐BMI relates to long‐term mortality risk in postmenopausal women, a group prone to metabolic changes after menopause.
Xiliang Wang +3 more
wiley +1 more source
2025 International Expert Practical Guide on the Use of the Pentaspline Pulsed Field Ablation System in Atrial Fibrillation Ablation Procedures. [PDF]
Chen S +22 more
europepmc +1 more source

